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ABSTRACT
Recent data suggest reduced indices of vascular repair in South Asian men, a group at
increased risk of cardiovascular events. Outgrowth endothelial cells (OEC) represent an attrac-
tive tool to study vascular repair in humans and may offer potential in cell-based repair
therapies. We aimed to deﬁne and manipulate potential mechanisms of impaired vascular
repair in South Asian (SA) men. In vitro and in vivo assays of vascular repair and angiogenesis
were performed using OEC derived from SA men and matched European controls, prior deﬁn-
ing potentially causal molecular mechanisms. SA OEC exhibited impaired colony formation,
migration, and in vitro angiogenesis, associated with decreased expression of the proangio-
genic molecules Akt1 and endothelial nitric oxide synthase (eNOS). Transfusion of European
OEC into immunodeﬁcient mice after wire-induced femoral artery injury augmented re-
endothelialization, in contrast with SA OEC and vehicle; SA OEC also failed to promote angio-
genesis after induction of hind limb ischemia. Expression of constitutively active Akt1
(E17KAkt), but not green ﬂuorescent protein control, in SA OEC increased in vitro angiogene-
sis, which was abrogated by a NOS antagonist. Moreover, E17KAkt expressing SA OEC pro-
moted re-endothelialization of wire-injured femoral arteries, and perfusion recovery of
ischemic limbs, to a magnitude comparable with nonmanipulated European OEC. Silencing
Akt1 in European OEC recapitulated the functional deﬁcits noted in SA OEC. Reduced signaling
via the Akt/eNOS axis is causally linked with impaired OEC-mediated vascular repair in South
Asian men. These data prove the principle of rescuing marked reparative dysfunction in OEC
derived from these men. STEM CELLS 2014;32:2714–2723
INTRODUCTION
Outgrowth endothelial cells (OEC; also known
as late outgrowth endothelial progenitor cells
or endothelial colony forming cells) possess
the functional properties of vascular endothe-
lium, while exhibiting a progenitor hierarchy
and the capacity for signiﬁcant ex vivo expan-
sion [1]. These properties, and the potential to
easily derive autologous cells, make them an
ideal tool to study indices of endothelial repair
in samples from apparently healthy individuals
at risk of cardiovascular events; moreover, they
possess potential in translation as a cardiovas-
cular repair therapy. A growing body of evi-
dence supports reduced vascular repair in
association with diabetes and insulin resist-
ance, disorders linked with persistently poor
cardiovascular mortality and morbidity [2].
Many other studies have shown vascular dys-
function and insulin resistance from childhood
onwards in people of South Asian ethnicity,
and even in early adulthood, this group is at
increased relative risk of major vascular events
[3–5]. Moreover, in later life, South Asian eth-
nicity is associated with more diffuse coronary
artery disease and retinal microvascular rare-
faction [6, 7]. Our previous work has demon-
strated impaired vascular function and a
reduction in basal and exercise mobilized cir-
culating progenitor cells in healthy young
South Asian men as a result of reduced nitric
oxide (NO) bioavailability [8, 9]. Importantly,
one of the subsets of circulating progenitor
cells, we noted to be reduced in South Asian
men (CD341/CD452) is acknowledged as the
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TRANSLATIONAL AND CLINICAL
RESEARCH
likely primitive source of OEC [10, 11] We set out to deﬁne
the reparative capacity of OEC derived from South Asian
men, versus a control cohort of white European men, and
then establish how OEC dysfunction might be reversed.
MATERIALS AND METHODS
Subject Recruitment
Healthy white European and South Asian men were recruited
by poster advertisement. Ethnicity was deﬁned by subjects
from a list used in UK health-care monitoring [12]; subjects
deﬁning their ethnicity within subdivisions of “Asian or British
Asian” were deﬁned as South Asian; those within the subdivi-
sions of “white” were deﬁned as white European. Subjects
were eligible for inclusion if aged 18–40 years, free from any
chronic illness, not taking prescription medication, non-
smokers within the past year, and free from hypertension
(blood pressure> 160/90 mmHg), diabetes, and hypercholes-
terolemia (total cholesterol> 7 mmol/L). The homeostasis
index of insulin resistance was calculated as published previ-
ously [8]. A total of 12 white European and 12 South Asian
men were included. All participants provided written informed
consent, according to the declaration of Helsinki; ethical
approval was provided by the Harrogate and Leeds (Central)
research ethics committees.
OEC Culture
Peripheral blood mononuclear cells were harvested from 35 ml
venous blood using density gradient centrifugation (Ficoll, GE
Healthcare, UK; www.gelifesciences.com), and suspended in
EGM-2 medium with EGM-2 Bullet kit (Lonza, UK; http://
www.lonza.com) and 10% fetal calf serum (FCS). Cells were
seeded on ﬁbronectin and medium replaced daily for the ﬁrst
week, then on alternate days. After 3–4 weeks, cells with cobble-
stone morphology developed in OEC colonies [13]; cells exhibited
contact inhibition and were capable of serial passage. Endothelial
phenotype was conﬁrmed using ﬂow cytometry, demonstrating
almost universal expression of the endothelial markers CD31,
CD144, CD146, and CD309, along with almost absent expression
of the pan-leukocyte marker CD45 and the monocyte marker
CD14 (Supporting Information Fig. S1).
Flow Cytometry
OEC were washed twice in phosphate-buffered saline (PBS) and
then incubated with FcR blocker (Miltenyi Biotech, UK; https://
www.miltenyibiotec.com). Appropriate concentrations of the
following antibodies were then applied in separate tubes:
CD31-FITC, CD146-FITC, CD309-PE, CD45-APC, CD14-APC
(Miltenyi Biotech, UK), or CD144-PE (BD Biosciences, UK; www.
bdbiosciences.com); class and isotype speciﬁc control ﬂuores-
cent antibodies were used to gate nonspeciﬁc ﬂuorescence.
Cells were analyzed using a BD LSR-Fortessa cytometer with
FACS DiVa6 software (BD Biosciences, UK) and histogram over-
lays were formatted using FlowJo v.7 (Ashland, OR; www.
ﬂowjo.com).
Proliferation
Viable OEC were enumerated using hemocytometry at pas-
sage 2 and 4 (P2 and P4), with exclusion of Trypan blue
stained nonviable cells. The number of population doublings
between these points was calculated according to the equa-
tion log2 (population at P4/population at P2); the time in
days between P2 and P4 was divided by this ﬁgure to derive
a population doubling time.
Migration and Invasion Assays
An amount of 4 3 104 OEC suspended in basal EGM-2
medium (1% FCS, without other additives) were placed in the
upper compartment of modiﬁed Boyden chamber apparatus.
The lower compartment contained EGM-2 with 50 ng/ml vas-
cular endothelial growth factor (VEGF165; R&D Systems, UK;
www.rndsystems.com), 50 ng/ml insulin-like growth factor-1
(IGF-1; R&D Systems, UK), or vehicle alone (control). Wells, in
triplicate, were incubated for 24 hours. Membranes were
ﬁxed in 70% ethanol before mechanical removal of cells on
the upper surface, and hematoxylin/eosin staining; migrant
OEC were enumerated in 10 high power ﬁelds (HPF:
1.52 mm2) and expressed as the mean value per HPF. Invasion
assays were carried out in an identical manner, other than
using Boyden chamber inserts precoated with Matrigel (Corn-
ing, UK; www.corning.com), to deﬁne VEGF-directed invasion,
versus vehicle control.
In Vitro Angiogenesis
OEC (5 3 104 cells per milliliter in EGM-2 with 50 ng/ml
VEGF165 and 1% FCS) were seeded in triplicate on Matrigel-
coated plates for 24 hours; in a subset of experiments 0.1
mmol/L L-NG-nitro-L-arginine methyl ester (L-NMMA), a nitric
oxide synthase (NOS) antagonist, was also added to culture
medium. Tubule formation was deﬁned as participation in
contiguous polygonal structures; mean number of tubular
structures per HPF was calculated based upon data collected
in 10 HPF.
Senescence
Sub-conﬂuent third passage LEPC were studied using a senes-
cence associated b-galactosidase staining kit (Cell Signaling,
UK; www.cellsignal.com); senescent EPCs were counted by
two-blinded independent operators (inter-observer agree-
ment: r5 0.99) using Image J software (National Institutes of
Health, MD; imagej.nih.gov/ij/) and expressed as percentage
total cells.
Survival Assay
Sub-conﬂuent OEC were placed in basal EGM-2 medium with
0.5% heat inactivated FCS, 20 ng/ml recombinant human
tumor necrosis factor (TNF)-a (R&D systems, UK), and 500 mM
hydrogen peroxide (Sigma), then incubated for 24 hours at
37C in 1% O2 and 5% CO2, to mimic an ischemic tissue
milieu [14]. LDH activity was measured in the conditioned
medium and normalized to total cellular LDH using a commer-
cially available kit (Sigma, UK; www.sigmaaldrich.com).
Western Blotting
Total protein of 30 mcg from cellular lysates was loaded onto
4–12% SDS-PAGE gels (Invitrogen, UK; www.lifetechnologies.com)
and electrophoresed under reducing conditions before trans-
fer to PVDF membranes. Membranes were probed with pri-
mary antibody (anti-Akt [Cell Signaling Technology; Boston,
MA], anti-endothelial NOS (eNOS) [BD Biosciences, UK], anti-
phospho S473 Akt [Cell Signaling Technology; Boston, MA],
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anti-phospho S1177 eNOS [BD Biosciences, UK], or anti-beta-
actin [Santa Cruz Biotechnology, Dallas, TX; www.scbt.com])
overnight in 5% skimmed milk in tris buffered saline (TBS)-
Tween buffer, followed by horse radish peroxidase (HRP)-
conjugated secondary antibody for an hour. Proteins were
visualized using enhanced ECL kit (Amersham Biosciences, UK;
www.gelifesciences.com).
Polymerase Chain Reaction
Total RNA was extracted from OEC using TRIZOL (Sigma-
Aldrich, UK). Equal quantities of RNA were reverse transcribed
using reverse transcription kit (Applied Biosystems, UK;
www.lifetechnologies.com) following manufacturer’s protocol.
Real-time PCR was performed using the following primers
using SYBR-based assay (Applied Biosystems, UK: 7900HT) and
beta-actin normalization:
eNOS forward, 50-CTG-GAG-CAC-CCC-ACG-CT-30
eNOS reverse, 50-AGC-GGT-GAG-GGT-CAC-ACA-G-30
Akt1 forward, 50-CCT-TCC-TCA-CAG-CCC-TGA-AGT-30
Akt1 reverse, 50-CCG-GGA-CAG-GTG-GAA-GAA-C-30
Beta-actin forward, 50-CGT-GAA-AAG-ATG-ACC-CAG-ATC-A-30
Beta-actin reverse, 50-TGG-TAC-GAC-CAG-AGG-CAT-ACA-G-30
Akt Activity
Akt kinase activity was analyzed by nonradioactive
immunoprecipitation-kinase assay according to manufacturer’s
protocol (Cell Signaling Technology; Boston, MA). Cell extracts
of 30 mcg were incubated with immobilized Akt 1G1 monoclo-
nal antibody. After extensive washing, the kinase reaction was
performed at 30C for 30 minutes in the presence of 200 mM
cold ATP and GSK-3 substrate. Phospho-GSK-3 was measured by
Western blot, using phospho-GSK-3a/b (Ser-21/9) antibody.
Animals
A 9- to 13-week-old (weight 25–33 g) male immunodeﬁcient
CD1 nude mice (Charles River Labs, UK; www.criver.com),
housed in isolators with 12-hour light–dark cycle, were used
in all experiments; standard diet was provided ad libitum.
Experiments were performed under license from the UK
Home Ofﬁce, observing standard animal welfare regulations.
Vascular Injury and Analysis
As published [15], mice were anesthetized with isoﬂurane
before femoral arteriotomy and three 1.5-cm passages of a
0.014-inch-diameter angioplasty guidewire (Hi-Torque Cross-IT
200XT; Abbott Vascular, UK; www.abbottvascular.com); the
vessel was then ligated and skin closed. The contralateral
artery underwent sham operation, without arteriotomy or
wire injury. Animals received buprenorphine 0.25 mg/kg.
3x105 CMDiI (Invitrogen, UK) labeled OEC in EBM2 (or EBM2
without cells, as control) were transfused into the external
iliac vein immediately after injury. Injured and contralateral
femoral arteries were explanted 4 days later after injection of
50 ml 5% Evans Blue dye via the inferior vena cava and perfu-
sion ﬁxation with 4% paraformaldehyde in PBS. Re-
endothelialization was assessed in en face specimens, deﬁned
as the region of absent Evan’s blue staining in relation to a
total area of a 5-mm section of vessel, commencing 5 mm
distal to the aortic bifurcation. Vessels were then blocked
(Serum free protein block, DAKO, UK; www.dako.com) and
incubated with a rabbit polyclonal antibody to mouse/human
CD31 (ab28364, Abcam, UK; www.abcam.com) followed by a
goat polyclonal anti-rabbit conjugated to Chromeo642
(ab60319, Abcam, UK), then mounted on slides with DAPI
(DAPI-Fluoromount-G, Southern Biotech, AL; www.southern-
biotech.com) to deﬁne nuclei. Confocal microscopy (Zeiss LSM
510 META Axioplan 2 Zeiss, UK; www.zeiss.co.uk) was used to
count adherent OEC, deﬁned by nuclei with peripheral DiI and
Chromeo642 ﬂuorescence, per square millimeter (mm2). In a
separate series of experiments, identical vascular injury and
transfusion protocols were performed, and vessels were
explanted 4 weeks later, with subsequent confocal analysis to
determine long-term engraftment of OEC. All murine studies
and analysis were performed by researchers blinded to
“treatment” allocation.
Hind-Limb Ischemia and Analysis
Mice were anesthetized with isoﬂurane before dissecting the
left femoral vessels, ligating the femoral artery proximally at
the inguinal ligament and distally at the bifurcation to saphe-
nous and popliteal vessels, and excising the intervening arte-
rial segment. Six hours later, [16] 3 3 105 CMDiI (Invitrogen,
UK) labeled OEC in EBM2 (or EBM2 without cells, as control)
were transfused into the right femoral vein at the time of
contralateral sham surgery. Laser Doppler analysis (Moor
LDI2-HR, Moor systems, UK; gb.moor.co.uk) of ischemic and
sham-injured limbs was then performed, in a temperature
controlled environment, to conﬁrm induction of ischemia.
Images were analyzed (MoorLDI software, Version 5.3, Moor
systems, UK) to derive an ischemic to non-ischemic limb per-
fusion ratio, based upon ﬂux below the level of the inguinal
ligament. On day 14, laser Doppler analysis was repeated to
deﬁne limb perfusion recovery, before perfusion ﬁxation with
4% paraformaldehyde and harvesting of ischemic and contra-
lateral gastrocnemius muscle. Muscle specimens were embed-
ded in OCT (Tissue-Tek OCT compound, Sakura, Netherlands)
before snap freezing in liquid nitrogen and cryosectioning at
10 mm thickness. Specimens were then blocked (Serum free
protein block, DAKO, UK) and incubated with a rabbit polyclo-
nal antibody to mouse/human CD31 (ab28364, Abcam, UK)
followed by a goat polyclonal anti-rabbit conjugated to Chro-
meo642 (ab60319, Abcam, UK), then mounted on slides with
DAPI (DAPI-Fluoromount-G, Southern Biotech, AL) to deﬁne
nuclei. Confocal microscopy (Zeiss LSM 510 META Axioplan 2)
was used to count engrafted OEC, deﬁned by nuclei with
peripheral DiI and Chromeo642 ﬂuorescence, per mm2.
SIN-Lentiviral Vector Production and Transduction
pSINCSGWdlNot1 was a kind gift of Dr. Yashiro Idea (Mayo Clinic,
Minnesota) [17]. The enhanced green ﬂuorescent protein (EGFP)
cassette of pSINCSGWdlNot1 was replaced by E17KAkt to gener-
ate pHVSLS2. The SIN-lentiviral vectors were generated in
accordance to established protocols [18], and were titred using
QuickTiter Lentivirus Titer Kit (Lentivirus-Associated HIV p24
ELISA kit [Cell Biolabs; San Diego, CA; www.cellbiolabs.com]) in
accordance with manufacturer’s protocol. Semi-conﬂuent sec-
ond passage OEC were transduced at one moi (multiplicity of
infection) of appropriate lentiviral vector for use 4 days later.
Akt1 Silencing
Sub-conﬂuent OEC were transfected with 20 nm Akt1 or con-
trol scrambled siRNA (Invitrogen) using Lipofectamine
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RNAiMax (Invitrogen), according to the manufacturer’s
instructions. Conﬁrmation of Akt1 knockdown and functional
studies, were conducted 48 hours later.
Statistical Analysis
Data are presented as mean (standard error of mean) and
groups compared with Student’s t-tests or paired t-tests as
appropriate. Statistical signiﬁcance is deﬁned as p< .05.
RESULTS
We recruited a cohort of apparently healthy SA men and
matched white European (WE) controls (n5 12 per group) to
assess basal abundance and function of OEC, before assessing
strategies to optimize their therapeutic efﬁcacy. Groups were
well matched for demographic factors and established cardio-
vascular risk factors, though relative insulin resistance was
apparent in the SA cohort (Table 1).
SA OEC are Dysfunctional In Vitro
OEC colony formation was markedly reduced in SA men (Fig.
1A; Supporting Information Fig. S1A), suggesting a lower
abundance of circulating progenitors; OEC phenotype was
conﬁrmed using ﬂow cytometry, showing almost universal
expression of endothelial markers CD31, CD144, CD146, and
CD309, along with almost absent expression of the pan-
leukocyte marker CD45 and monocyte marker CD14 (Support-
ing Information Fig. S1C). The surface marker proﬁle of OEC
derived from WE and SA men was comparable (Supporting
Information Fig. S1D). The proliferative rate and migration
toward physiologically relevant stimuli (VEGF and IGF-1) were
blunted in SA OEC (Fig. 1B, 1C; Supporting Information Fig.
S2). VEGF stimulated in vitro angiogenesis, measured by
tubule formation on Matrigel, was also signiﬁcantly reduced
(Fig. 1D; Supporting Information Fig. S2). SA OEC were also
more senescent as a population as deﬁned by b-galactosidase
staining (Fig. 1E; Supporting Information Fig. S2). The capacity
of OEC derived from WE and SA men to invade a Matrigel
layer was similar (Fig. 1F). Concentrations of the proangio-
genic molecules protein kinase-B (Akt1) and eNOS were mark-
edly reduced in SA OEC at protein level (including the
“activated” S473 and S1177 phosphorylated forms, respec-
tively) (Fig. 2A–2D). eNOS, but not Akt1, mRNA was less abun-
dant in SA OEC (Supporting Information Fig. S3).
SA OEC Are Dysfunctional In Vivo
To probe the in vivo relevance of our in vitro studies, equal
numbers of OEC were transfused intravenously into CD1
immunodeﬁcient mice immediately after wire-induced luminal
injury of the common femoral artery, with vehicle medium
serving as control. After 4 days, re-endothelialization was
assessed using Evans blue staining of the injured and contra-
lateral noninjured vessel to indicate persistent endothelial
Table 1. Demographic and cardiovascular risk data
South
Asian
White
European
p
value
Age (years) 30.9 (1.2) 29.7 (1.1) NS
Body mass index (kg/m2) 24.1 (0.7) 22.4 (0.5) NS
Waist–hip ratio 0.85 (0.01) 0.84 (0.01) NS
Systolic blood pressure (mmHg) 116 (2.3) 116 (2.5) NS
Diastolic blood pressure (mmHg) 70 (1.6) 69 (1.6) NS
Total cholesterol (mmol/l) 4.6 (0.1) 4.7 (0.1) NS
Triglycerides (mmol/l) 1.1 (0.1) 1.2 (0.1) NS
Glucose (mmol/l) 4.8 (0.1) 4.6 (0.1) NS
Insulin (mu/l) 5.6 (0.8) 2.9 (0.3) .009
HOMA-IR 1.2 (0.2) 0.6 (0.1) .008
All data are expressed as mean (SEM).
Abbreviations: HOMA-IR, homeostasis index of insulin resistance; NS,
nonsigniﬁcant.
Figure 1. In vitro characterization of outgrowth endothelial cell (OEC) abundance and function. In South Asian men, compared with
white European controls, OEC. (A): colony formation is reduced (n5 8); (B) population doubling time is prolonged (n5 8); (C) migration
to vascular endothelial growth factor and insulin-like growth factor-1 is impaired (n5 8); (D) in vitro angiogenesis is reduced (n5 8); (E)
SENESCENCE is increased (n5 8); (F) invasion through a Matrigel layer is comparable. All data are displayed as mean6 SEM; *, p< .05.
Abbreviation: OEC, outgrowth endothelial cell.
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denudation (Fig. 3A). OEC derived from WE subjects signiﬁ-
cantly augmented re-endothelialization, whereas the femoral
arteries of mice exposed to SA OEC were indistinguishable
from those receiving vehicle (Fig. 3B). Confocal microscopy
revealed fewer adherent ﬂuorescently tagged OEC, coexpress-
ing the endothelial surface marker CD31, in the intima of
specimens from recipients of SA OEC (Fig. 3C, 3D; Supporting
Information Fig. S4). In a separate series of experiments, OEC
were transfused into CD1 mice 6 hours after induction of
hind-limb ischemia by ligation of the femoral artery; limb
ischemia was conﬁrmed immediately after surgery using laser
Doppler, with the sham operated contralateral limb serving as
control. Fourteen days later, laser Doppler analysis was
repeated before harvesting of the gastrocnemius muscle for
confocal microscopic enumeration of engrafted ﬂuorescently
tagged OEC coexpressing CD31. Compared with mice receiving
vehicle medium alone, WE OEC signiﬁcantly augmented ische-
mic limb perfusion at 14 days, while SA OEC had no impact
(Fig. 3E, 3F); numbers of engrafted CD31 expressing OEC were
also signiﬁcantly greater in mice receiving WE versus SA OEC
(Fig. 3G, 3H; Supporting Information Fig. S5). Hence, SA OEC
appeared unable to promote conduit arterial repair or ische-
mia induced angiogenesis, in contrast with control WE OEC.
Restoration of Akt Activity Rescues SA OEC Function
In Vitro
Based upon the upstream location of Akt relative to eNOS,
and literature demonstrating the critical role of both mole-
cules in angiogenesis [19–21], we elected to augment OEC
Akt activity in SA OEC using lentiviral vector gene delivery of
a constitutively active Akt1 mutant (E17KAkt—Supporting
Information Fig. S6A) [22, 23]. Self-inactivating lentiviral vec-
tors (LVHVSLS2 and LVSinCSGWdlNot1) were used to intro-
duce E17KAkt or EGFP (control), with viral titers chosen to
augment SA OEC phospho-Akt S473 content approximately
threefold, to achieve levels comparable to control European
OEC (Supporting Information Fig. S6B). E17KAkt expressing SA
OEC exhibited increased phospho-Akt S473 content and Akt
activity as measured using a cell free GSK phosphorylation
assay (Fig. 4A, 4B); Akt activity in EGFP expressing and native
SA OEC was comparable (Fig. 4B). E17KAkt expressing SA OEC
also demonstrated increased total- and phospho-eNOS S1177
(Fig. 4C; Supporting Information Fig. S7A); this was associated
with augmented in vitro VEGF induced angiogenesis, a phe-
nomenon which could be completely blocked by the NOS
antagonist L-NMMA (Fig. 4D). Moreover, E17KAkt expressing
SA OEC demonstrated markedly enhanced survival in a simu-
lated ischemic environment, comprising of hypoxia, serum
deprivation, oxidative stress, and the inﬂammatory mediator
TNF-a (Fig. 4E). These data implicate increased Akt/eNOS sig-
naling as contributing to the augmented function of E17KAkt
expressing SA OEC in vitro. Migration of E17KAkt and EGFP
expressing OEC toward VEGF were comparable (Supporting
Information Fig. S7B).
Restoration of Akt Activity Rescues SA OEC Function
In Vivo
Intravenous transfusion of EGFP expressing SA OEC was asso-
ciated with unchanged femoral artery re-endothelialization,
whereas E17KAkt expressing OEC augmented re-
endothelialization to a magnitude comparable with nontrans-
duced European cells (Fig. 5A). Confocal microscopy of injured
femoral artery specimens revealed signiﬁcantly greater num-
bers of engrafted CD31 expressing OEC in mice exposed to
E17KAkt, versus EGFP, expressing SA OEC (Fig. 5B). Fourteen
days after induction of hind-limb ischemia, E17KAkt SA OEC
Figure 2. Basal- and insulin-stimulated phosphorylation of Akt and endothelial nitric oxide synthase (eNOS). (A, B): Total and phospho-
S473 Akt are reduced (n5 7); (C, D) total and phospho-S1177 eNOS are reduced (n5 7). All data are displayed as mean6 SEM; *, p< .05.
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also demonstrated a restored capacity to augment ischemic
limb perfusion, in contrast to EGFP expressing SA OEC (Fig.
5C; Supporting Information Fig. S8). Ischemic limb muscula-
ture exposed to E17KAkt expressing SA OEC also demon-
strated increased numbers of engrafted CD31 OEC, when
compared with control mice receiving EGFP expressing SA
OEC (Fig. 5D). Hence, augmenting Akt activity in SA OEC is
associated with restored capacity of infused progenitors to
promote vascular repair and regeneration.
Silencing of Akt1 in WE OEC Recapitulates the
Dysfunction Noted in SA OEC
To support the causal role of Akt1 in our preceding observa-
tions, we went on to silence Akt1 in OEC derived from WE
men. In comparison with scrambled siRNA transfected con-
trols, Akt1 siRNA transfected OEC exhibited a mean 51%
reduction in Akt1 protein (Fig. 6A), broadly reproducing the
reduction in Akt1 noted in SA OEC. This was associated with
markedly reduced migration toward VEGF in Boyden chamber
apparatus (Fig. 6B). When infused into CD1 mice after wire-
induced femoral artery injury, Akt1 knockdown OEC less effec-
tively promoted re-endothelialization (Fig. 6C), and engrafted
in markedly reduced numbers (Fig. 6D).
DISCUSSION
Our data are the ﬁrst to demonstrate the dysfunction of OEC
derived from apparently healthy South Asian men using a
detailed array of in vitro and in vivo assessments; further-
more, these functional deﬁcits have been linked to molecular
abnormalities relevant to vascular repair. In particular, by
demonstrating improved SA OEC function after lentiviral aug-
mentation of Akt activity, we have causally implicated this
molecule in the OEC dysfunction related to South Asian eth-
nicity. Further support is provided by the observation that
silencing of Akt1 in WE OEC mimics the dysfunction of SA
OEC, both in vitro and in vivo. Moreover, our work provides
the ﬁrst demonstration of rescued in vivo OEC function in
Figure 3. In vivo assessment of outgrowth endothelial cell (OEC) function. (A): Representative injured (left) and noninjured (right) femoral
arteries from mice receiving white European (WE) OEC (left panel) and South Asian (SA) OEC (right panel) demonstrating greater residual
endothelial denudation, indicated by Evan’s blue staining, in the injured vessel exposed to SA OEC (scale bar5 5mm); (B) femoral artery re-
endothelialization is augmented in mice receiving WE, but not SA OEC, nor vehicle (n5 7 in all groups); (C) representative confocal micros-
copy of injured intima from vessels exposed to WE (left) and SA (right) OEC, demonstrating cell engraftment and CD31 coexpression (Scale
bar5 50 mm; blue—DAPI, red—CMDiI cell tracker-labeled OEC; Yellow—Chromeo 642 anti-CD31); (D) greater numbers of OEC engraft in
vessels exposed to WE than SA OEC (n5 5 per group); (E) representative laser Doppler ﬂux images (day 14 post-operatively) from mice
receiving WE (left) and SA (right) OEC after induction of limb ischemia; (F) limb blood ﬂow, while comparable post-operatively, is greater
on day 14 in mice receiving WE OEC than those receiving vehicle or SA OEC (n5 5 per group); (G) representative confocal microscopy of
ischemic muscle from mice receiving WE (left) and SA (right) OEC, showing cell engraftment and CD31 coexpression (white arrows) (scale
bar5 50mm; blue—DAPI; red—CMDiI cell tracker-labeled OEC; purple—Chromeo642 anti-CD31); (H) greater numbers of OEC engraft in
ischemic muscle exposed to WE than SA OEC (n5 5 per group). All data are displayed as mean6 SEM; *, p< .05; p .05 is denoted by
nonsigniﬁcant. Enlarged versions of panels (C) and (G), with separation of color channels, are presented in the Supporting Information ﬁg-
ures. Abbreviations: NS, nonsigniﬁcant; OEC, outgrowth endothelial cell; SA, South Asian; WE, white European.
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cells derived from subjects at increased risk of major cardio-
vascular events, a potentially important step in deﬁning future
cardiovascular repair therapies.
A growing body of evidence supports the elevated cardio-
vascular risk associated with South Asian ethnicity, compared
with European ethnicity [4, 24, 25]; insulin resistance and dia-
betes have been strongly implicated in this phenomenon [25].
Our previous work has demonstrated important abnormalities
in the vascular biology of apparently healthy, but insulin
resistant, South Asian men [8, 9]. Endothelial dysfunction/
damage were suggested by impaired ﬂow mediated vasodila-
tation and elevation of circulating endothelial microparticles,
while marked reductions in circulating progenitor subsets
were apparent. Furthermore, physiological mobilization of
progenitors (the CD341/CD452 fraction of which contain OEC
precursors) [10, 11] appeared reduced in SA men, as a result
of reduced NO bioavailability [8]. Our current data comple-
ment and substantially advance these observations, demon-
strating clear perturbation in the function of ex vivo
expanded OEC, and mechanistically implicating impaired Akt
signaling in this process. The causality of such impaired signal
transduction in SA OEC is unclear, although abundant data
support the role of Akt, and downstream eNOS, signal trans-
duction in promoting vascular repair and abrogating athero-
genesis [19–21, 26, 27]. Importantly, our data also support
the capacity of E17KAkt to augment phospho-eNOS S1177, a
surrogate of eNOS activity, and demonstrate that the
increased in vitro angiogenesis associated with E17KAkt
expression can be blocked with a NOS antagonist.
As discussed earlier, insulin resistance is thought to be a
major contributor to the increased cardiovascular risk noted
in South Asian populations, based upon often circumstantial
epidemiological and in vitro data. It is therefore interesting to
speculate as to whether insulin resistance could underlie the
reparative dysfunction noted in OEC derived from SA men.
Certainly, impaired Akt/eNOS signal transduction is deﬁning
characteristic of vascular insulin resistance, and we have dem-
onstrated this phenomenon here in OEC, and previously in
healthy South Asian men using vascular ultrasound studies
[8]. Moreover, we have previously demonstrated in mice
haplo-insufﬁcient for the insulin receptor, that globally
reduced insulin signaling is associated with reduced vascular
Figure 4. In vitro assessment of outgrowth endothelial cell (OEC) expressing constitutively active Akt. (A): Phospho-S473 Akt content is
increased in E17K expressing cells, relative to EGFP expressing, or untreated South Asian (SA) OEC (representative immunoblots
included; n5 6 in all studies); (B) Akt activity is increased in E17K expressing cells, relative to EGFP expressing or untreated SA OEC (rep-
resentative immunoblots included; n5 6 in all studies); (C) phospho-S1177 endothelial nitric oxide synthase (eNOS) is increased in E17K
expressing cells, relative to EGFP expressing or untreated SA OEC (representative immunoblots included; n5 6 in all studies); (D) SA
OEC expressing E17KAkt, but not EGFP, demonstrate augmented vascular endothelial growth factor (VEGF) induced in vitro angiogenesis,
which is completely abrogated by antagonism of NOS with L-NG-nitro-L-arginine methyl ester; (E) SA OEC expressing E17KAkt exhibit
greater survival than paired SA OEC expressing EGFP when exposed to a simulated ischemic environment (n5 4 per group). All data are
displayed as mean6 SEM; p< .05 is denoted by *. Abbreviations: EGFP, enhanced green ﬂuorescent protein; eNOS, endothelial nitric
oxide synthase; GFP, green ﬂuorescent protein; NS, nonsigniﬁcant; VEGF, vascular endothelial growth factor.
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repair potentially as a result of defects in circulating progeni-
tor cell function [15]. Ultimately however, whether the signal-
ing abnormalities noted in SA OEC are due to insulin
resistance, ethnicity, or both, is impossible to ascertain in
human studies, due to technical and ethical considerations.
Interestingly, other published data using a murine model
of myocardial infarction suggest that the reparative potential
of OEC derived from healthy volunteers can be augmented by
combined over-expression of wild-type Akt1 and heme-
oxygenase-1 [14]. In agreement with our data, this work may
suggest that Akt plays an important as a survival factor for
OEC, which are likely to be exposed to noxious stimuli in
ischemic tissues undergoing repair. Moreover, their data con-
curs with our observations regarding the beneﬁcial impact of
Akt upon OEC mediated angiogenesis in vivo. Our data
advance these observations by showing that it is possible to
rescue the diminished reparative capacity of OEC derived
from people in a group at high risk of cardiovascular events.
OEC are recognized as representing an attractive form of
autologous cell based cardiovascular repair therapy, given their
close mimicry of endothelial phenotype and capacity for signiﬁ-
cant ex vivo expansion and manipulation [1]. Indeed, they have
already been demonstrated to augment myocardial angiogene-
sis and stimulate beneﬁcial left ventricular remodeling in large
animal models of myocardial infarction [28]. Hence, these cells
may offer the prospect of preventing or retarding cardiovascu-
lar morbidity in groups of patients at high risk of adverse
events. As far as we are aware, our data is the ﬁrst to demon-
strate restoration of dysfunctional human OEC mediated vascu-
lar repair in vivo, an important proof of principle for human
autologous cell based vascular repair therapy. Equally, our
observations may be relevant to the development of pharmaco-
logical strategies to promote endogenous vascular repair in
South Asian populations, which may even be relevant to insulin
resistant populations in other ethnic groups. However, this goal
may be more effectively achieved by ﬁrst identifying the
cause(s) of reduced Akt content and signaling in SA OEC—this
will be an important goal of future studies.
While our data offer important insights into the mecha-
nisms underlying abnormal indices of vascular repair in South
Asian men, it is important to acknowledge some limitations.
First, human cell-based cardiovascular repair therapy remains
relatively nascent, with bone marrow-derived mononuclear
cells being the only fraction to have been studied in any
detail (and data from large phase III studies are awaited [29]).
Many other cell-sources have been applied in small phase I
trials, although these give little meaningful indication of ther-
apeutic efﬁcacy [30]; OEC have not yet been administered to
humans, but large animal studies suggest a greater efﬁcacy
than mesencyhmal stem cells in promoting recovery after
Figure 5. In vivo assessment of outgrowth endothelial cell (OEC) expressing constitutively active Akt. () Expression of E17KAkt, but not
EGFP, in South Asian (SA) OEC rescues capacity to re-endothelialise injured femoral artery, when compared with unmodiﬁed white Euro-
pean (WE) OEC (n5 6 in E17KAkt and EGFP groups and n5 7 in all other groups). (B): Engraftment of OEC into the injured femoral
artery is signiﬁcantly increased in SA OEC expressing E17KAkt versus EGFP (n5 5 per group); (C) despite similar post-operative limb-
ischemia, perfusion recovery 14 days later is only augmented in mice receiving SA OEC expressing E17KAkt, not EGFP (n5 5 per group);
(D) engraftment of OEC into the ischemic gastrocnemius muscle is signiﬁcantly increased in SA OEC expressing E17KAkt, versus EGFP
(n5 5 per group). All data are displayed as mean6 SEM; *, p< .05. Abbreviations: EGFP, enhanced green ﬂuorescent protein; NS, non-
signiﬁcant; OEC, outgrowth endothelial cell; SA, South Asian; WE, white European.
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myocardial infarction [28]. The capacity to rescue the repara-
tive properties of dysfunctional autologous progenitors has
been raised as an important obstacle to clinical translation of
such therapies [31]; in this regard, our investigation provides
an important proof of principal in OEC. As discussed earlier,
cell based therapies may not be the only means of promoting
vascular repair—our data may also suggest avenues of further
research into its pharmacological manipulation. However,
chronic over-activation of Akt has also been linked with
diminished indices of vascular repair [32, 33], and so it may
desirable to transiently augment vascular or OEC Akt activity
when vascular repair and regeneration is most desired. By
understanding why Akt signaling is impaired in SA OEC, it may
also be possible to develop more targeted therapies which
circumvent this issue.
CONCLUSION
In conclusion, we have demonstrated that OEC derived from
healthy South Asian men exhibit signiﬁcant blunting of vascu-
lar reparative function in vitro and in vivo, which is mecha-
nistically linked to reduced Akt/eNOS signaling. By
augmenting Akt signaling using a lentiviral vector, we have
provided the ﬁrst ever demonstration that dysfunction of
OEC from humans at increased cardiovascular risk can be
corrected.
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Figure 6. Akt1 silencing in white European (WE) outgrowth endothelial cell (OEC) recapitulates the functional abnormalities noted in
South Asian (SA) OEC. (A): Akt1 expression was reduced by a mean of 51% in WE OEC exposed to Akt1 siRNA (Akt si.) versus paired
control samples exposed to scrambled siRNA (sc. si.)(n5 6 per group); (B) silencing of Akt1 reduced migration toward vascular endothe-
lial growth factor (VEGF) (n5 5 per group); (C, D) when infused after femoral arterial injury, Akt1 silenced OEC were less able to pro-
mote re-endothelialisation (C) and engrafted less frequently into the injured vessel intima (D) (n5 6 per group). All data are displayed
as mean6 SEM; *, p< .05. Abbreviation: OEC, outgrowth endothelial cell.
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